Comparison of the effects of several drugs on tissue uptake of labeled thyroxine and triiodothyronine in the presence of rat plasma in vitro

5: Final Report on the Safety Assessment of 2-Methylresorcinol and Resorcinol

2-Methylresorcinol and Resorcinol are most frequently used in cosmetic hair dye formulations at concentrations between 1 and 5%. The results of cutaneous and oral feeding studies have indicated that both 2-Methylresorcinol and resorcinol are readily absorbed by rodents and are rapidly eliminated. Acute oral toxicity studies indicate that 2-Methylresorcinol is moderately toxic and Resorcinol is slightly to moderately toxic. Subchronic feeding and dermal studies of bothingredients produced no significant effects. A chronic dermal study was uneventful. Significant skin effects were observed in mice, but not in rabbits, following dermal application of Resorcinol at 5%. A 10% Resorcinol solution was not irritating to guinea pigs. A 2.5% 2-Methylresorcinol solution was classified as a primary irritant in rabbits, but 10% 2-Methylresorcinol was not irritating to guinea pigs. 2-Methylresorcinol was not an ocular irritant at 2.5%, but irritation was produced at 5% concentration in unwashed rabbit eyes. Neither 2-Methylresorcinol at 5% nor Resorcinol at 3% produced sensitization in guinea pigs. 2-Methylresorcinol was not photoallergenic to guinea pigs but was a sensitizer at 10%. Resorcinol was not photoallergenic to guinea pigs but was a sensitizer at 10%. Resorcinol and 2-Methylresorcinol were nonmutagenic in microbial and tissue culture assays for mutagenicity. Topically applied hair dyes containing 2-Methylresorcinol and Resorcinol were negative for carcinogenicity. Resorcinol showed no cocarcinogenic potential when tested on mice and rats. 2-Methylresorcinol at 3% concentration produced no evidence of irritation or sensitization in human subjects. Resorcinol was a mild skin irritant and rare sensitizer in clinical testing, but not when tested on nonclinical groups. On the basis of the available animal and clinical data, it is concluded that 2-Methylresorcinol and Resorcinol are safe as cosmeticingredients in the present practices of use and concentrations.

Microbodies in experimentally altered cells. II. The relationship of microbody proliferation to endocrine glands

The liver cells of intact male rats given ethyl-alpha-p-chlorophenoxyisobutyrate (CPIB) characteristically show a marked increase in microbodies and in catalase activity, while those of intact female rats do not. In castrated males given estradiol benzoate and CPIB the increase in catalase activity and microbody proliferation is abolished, while in castrated females given testosterone propionate and CPIB the livers show a marked increase in microbodies and in catalase activity. No sex difference in microbody and catalase response is apparent in fetal and neonatal rats. Both sexes show a sharp rise in catalase activity on the day of birth, with a rapid decline at 5 days after birth. Thyroidectomy abolishes the hypolipidemic effect of CPIB in rats, but microbody proliferation and increase in catalase activity persists in thyroidectomized male rats, indicating that microbody proliferation can be independent of hypolipidemia. Adrenalectomy does not alter appreciably the microbody-catalase response to CPIB. These experiments demonstrate that (1) in adult rats, hepatic microbody proliferation is dependent to a significant degree upon male sex hormone but is largely independent of thyroid or adrenal gland hormones; (2) hepatic microbody proliferation is independent of the hypolipidemic effect of CPIB; (3) displacement of thyroxine from serum protein may not be sufficient cause for stimulation of microbody formation.